Implantable device to beat high blood pressure
An implantable device that reduces blood pressure by sending electrical signals to the brain has been created by a group of researchers in Germany.
May 8, 2014
0
0
Archive: 08/05/2014
Vermont law requires labeling of GMO foods
Vermont's governor signed a law Thursday that puts the state on the path to be the first in the U.S. to require labeling of genetically modified foods, and he promptly announced an online fundraiser to fight expected legal ...
May 8, 2014
Middle-aged at risk from rows with family, neighbours
Think again before you pick another fight with your tearaway daughter or go head-to-toe once more with the people next door over their late-night parties.
May 8, 2014
From age 30 onwards, inactivity has greatest impact on women's lifetime heart disease risk
From the age of 30 onwards, physical inactivity exerts a greater impact on a woman's lifetime risk of developing heart disease than the other well-known risk factors, suggests research published online in the British Journal ...
May 8, 2014
Frequent arguments with family and friends linked to doubling in death risk in middle age
Frequent arguments with partners, relatives, or neighbours may boost the risk of death from any cause in middle age, suggests research published online in the Journal of Epidemiology & Community Health.
May 8, 2014
Hurricanes Katrina and Rita may have caused up to half of recorded stillbirths in worst hit areas
Hurricanes Katrina and Rita may have been responsible for up to half of all recorded stillbirths in the worst hit areas, suggests research published online in the Journal of Epidemiology & Community Health.
May 8, 2014
Short bursts of intense exercise before meals control blood sugar better than 1 continuous 30 minute session
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes) indicates that brief bursts of intense exercise before meals (termed exercise 'snacking' by the study authors) helps ...
May 8, 2014
Zontivity approved for people at high-risk of heart attack, stroke
(HealthDay)—Zontivity (vorapaxar) tablets have been approved by the U.S. and Drug Administration for people at high risk of heart attack or stroke.
May 8, 2014
